Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Oklahoma City, Oklahoma 73104


Purpose:

Objective: The goal is to improve peginterferon sensitivity in previous poor responders. "Sensitivity" here means the host's ability to kill more HCV. Design: Twenty poor responders to prior PIFN/RBV will be given 48 weeks of statin monotherapy. Veterans and civilians between the ages of 18 and 70 are eligible.


Criteria:

Inclusion Criteria: Hepatitis C positive by HCV RNA within 180 days. - No anti-HCV medicine within 30 days of screening Exclusion Criteria: - decompensated liver disease - severe cardiac disease (ejection fraction < 20% or uncontrolled angina) - unexplained muscle pain at time of screening - pregnancy - renal insufficiency (creatine clearance < 50 ml/min)


NCT ID:

NCT01377909


Primary Contact:

Principal Investigator
Ted Bader, M.D.
Department of Veterans Affairs


Backup Contact:

N/A


Location Contact:

Oklahoma City, Oklahoma 73104
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.